1,279
Views
8
CrossRef citations to date
0
Altmetric
Clinical focus: Mens Health - Review

Evaluation and treatment of urinary incontinence in the aging male

ORCID Icon & ORCID Icon
Pages 9-17 | Received 20 Aug 2020, Accepted 30 Sep 2020, Published online: 28 Oct 2020

References

  • Sahin-Onat A, Unsal-Delialioglu S, Güzel O, et al. Relationship between urinary incontinence and quality of life/depression in elderly patients. J Gerontol. 2014;5:86–90.
  • Matta R, Hird AE, Saskin R, et al. Is there an association between urinary incontinence and mortality? A retrospective cohort study. J Urol. 2020;203(3):591–597.
  • Suskind AM. Frailty and lower urinary tract symptoms. Curr Urol Rep. 2017;18(9):67.
  • Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–1315.
  • Hester AG, Kretschmer A, Badlani G. Male incontinence: the etiology or basis of treatment. Eur Urol Focus. 2017;3(4–5):377–384.
  • Stothers L, Thom D, Calhoun E. Urologic diseases in America project: urinary incontinence in males- demographics and economic burden. J Urol. 2005;173(4):1302–1308.
  • Patel M, Vellanki K, Leehey DJ, et al. Urinary incontinence and diuretic avoidance among adults with chronic kidney disease. Int Urol Nephrol. 2016;48(8):1321–1326.
  • Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–178.
  • Lightner DJ, Gomelsky A, Souter L, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558–563.
  • Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–336.
  • Coyne KS, Margolis MK, Kopp ZS, et al. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study. Urology. 2012;79(1):95–101.
  • National Institute of Diabetes and Digestive and Kidney Diseases. Definition & facts for bladder control problems (urinary incontinence); [ cited 2020 Aug 16]. Available from: https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-control-problems/definition-facts
  • Chen Z, Phan MD, Bates LJ, et al. The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection. Int Urogynecol J. 2018;29(12):1775–1782.
  • DuBeau CD. the aging lower urinary tract. J Urol. 2006;175:S11–15.
  • Hughes FM Jr, Sexton SJ, Jin H, et al. Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1β. Am J Physiol Renal Physiol. 2017;313(3):F603–F610.
  • Elbadawii A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol. 1993;150:1657–1667.
  • Lowalekar SK, Cristofarro V, Radisavljevic ZM, et al. Loss of bladder smooth muscle caveolae in the aging bladder. Neurourol Urodyn. 2012;31:586–592.
  • Aybek H, Aybek Z, Abban G, et al. Preventive effects of vitamin E against oxidative damage in aged diabetic rat bladders. Urology. 2011;77(2):508.e10-4.
  • Tapia CI, Khalaf K, Berenson K, et al. Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review. Health Qual Life Outcomes. 2013;11:13.
  • Pohar SL, Jones A. The burden of Parkinson disease (PD) and concomitant comorbidities. Arch Gerontol Geriatr. 2009;49:317–321.
  • Edwards DF, Hahn M, Dromerick A. Post stroke urinary loss, incontinence and life satisfaction: when does post-stroke urinary loss become incontinence? Neurourol Urodyn. 2006;25:39–45.
  • Chapple CR, Osman NI, Birder L, et al. Terminology report from the International Continence Society (ICS) working group on Underactive Bladder (UAB). Neurourol Urodyn. 2018;37(8):2928–2931.
  • Osman NI, Chapple CR, Abrams P, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014;65(2):389–398.
  • Uren AD, Cotterill N, Harding C, et al. Qualitative exploration of the patient experience of underactive bladder. Eur Urol. 2017;72:402–407.
  • Sandhu JS, Breyer B, Comiter C, et al. Incontinence after prostate treatment: AUA/SUFU guideline. J Urol. 2019;202(2):369–378.
  • Bruschini H, Simonetti R, Antunes A, et al. Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol. 2011;37(3):380–387.
  • Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol. 2006;50(5):969–980.
  • Lee YJ, Oh SA, Kim SH, et al. Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study. PLoS One. 2017;12(8):e0182230.
  • Bhojani N, Bidair M, Zorn KC, et al. Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 1-year results. Urology. 2019;129:1–7.
  • Tanneru K, Gautam S, Norez D, et al. Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. Int Urol Nephrol. 2020;52(6):999–1008.
  • McVary KT, Rogers T, Roehrborn CG. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019;126:171–179.
  • Shah AA, Gahan JC, Sorokin I. Comparison of robot-assisted versus open simple prostatectomy for benign prostatic hyperplasia. Curr Urol Rep. 2018;19(9):71.
  • Heesakkers J, Farag F, Bauer RM, et al. Pathophysiology and contributing factors in postprostatectomy incontinence: a review. Eur Urol. 2017;71(6):936–944.
  • Sacco E, Prayer-Galetti T, Pinto F, et al. Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. BJU Int. 2006;97(6):1234–1241.
  • Coughlin GD, Yaxley JW, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19(8):1051–1060.
  • Mock S, Leapman M, Stock RG, et al. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters. J Urol. 2013;190(5):1805–1810.
  • Polland A, Vertosick EA, Sjoberg DD, et al. Preoperative symptoms predict continence after post-radiation transurethral resection of prostate. Can J Urol. 2017;24(4):8903–8909.
  • Tamanini JTN, Pallone LV, Sartori MGF, et al. A populational-based survey on the prevalence, incidence, and risk factors of urinary incontinence in older adults-results from the “SABE STUDY”. Neurourol Urodyn. 2018;37(1):466–477.
  • Giraldo-Rodríguez L, Agudelo-Botero M, Mino-León D, et al. Epidemiology, progression, and predictive factors of urinary incontinence in older community-dwelling Mexican adults: longitudinal data from the Mexican Health and Aging Study. Neurourol Urodyn. 2019;38(7):1932–1943.
  • Stenzelius K, Mattiasson A, Hallberg IR, et al. Symptoms of urinary and faecal incontinence among men and women 75+ in relations to health complaints and quality of life. Neurourol Urodyn. 2004;23(3):211–222.
  • Son Y, Kwon BE. Overactive bladder is a distress symptom in heart failure. Int Neurourol J. 2018;22(2):77–82.
  • Bradley CS, Erickson BA, Messersmith EE, et al. Evidence of the impact of diet, fluid intake, caffeine, alcohol and tobacco on lower urinary tract symptoms: a systematic review. J Urol. 2017;198(5):1010–1020.
  • Bolat MS, Akdeniz E, Ozkaya S, et al. Smoking and lower urinary tract symptoms. Urol J. 2015;12(6):2447–2451.
  • Bauer SR, Grimes B, Suskind AM, et al. Urinary incontinence and nocturia in older men: associations with body mass, composition and strength in the health ABC study. J Urol. 2019;202(5):1015‐1021.
  • Malmsten UG, Milsom I, Molander U, et al. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol. 1997;158(5):1733–1737.
  • Griebling TL. Aging and geriatric urology. In: Partin AW, Peters CA, Kavoussi LR, et al., editors. Campbell-walsh-wein urology. 12th ed. Philadelphia, PA: Elsevier; 2020. p. 2905–2923.
  • Greer JA, Arya LA, Smith AL. Urinary incontinence: diagnosis and treatment in the elderly. Curr Transl Geriatr Exp Gerontol Rep. 2013;2:66–75.
  • Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:5–26.
  • Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23:322–330.
  • Shumaker SA, Wyman JF, Uebersax JS, et al. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence Program in Women (CPW) research group. Qual Life Res. 1994;3(5):291–306.
  • Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563–574.
  • Coyne KS, Matza LS, Thompson C, et al. The responsiveness of the OAB-q among OAB patient subgroups. Neurourol Urodyn. 2007;26(2):196–203.
  • Winters JC, Dmochowski RR, Goldman HB, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188:2464–2472.
  • Khoury AE, Dave S, Peralta-Del Valle MH, et al. Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder. BJU Int. 2008;101(2):223–226.
  • Imamura M, Williams K, Wells M, et al. Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database Syst Rev. 2015;(12):CD003505.
  • Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481–490.
  • Wing RR, Creasman JM, West DS, et al. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol. 2010;116:284–292.
  • Dallosso HM, McGrother CW, Matthews RJ, et al. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int. 2003;92(1):69–77.
  • Townsend MK, Jura YH, Curhan GC, et al. Fluid intake and risk of stress, urgency, and mixed urinary incontinence. Am J Obstet Gynecol. 2011;205(1):73.e1-73.e736.
  • Manonai J, Songchitsomboon S, Chanda K, et al. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Maturitas. 2006;54(2):135–140.
  • Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004;2004(1):CD002802.
  • Gibson JM, Thomas LH, Harrison JJ, et al.; ICONS Project Team and the ICONS Patient, Public and Carer Involvement Groups. Stroke survivors’ and carers’ experiences of a systematic voiding programme to treat urinary incontinence after stroke. J Clin Nurs. 2018;27(9–10):2041–2051.
  • Strączyńska A, Weber-Rajek M, Strojek K, et al. The impact of pelvic floor muscle training on urinary incontinence in men after radical prostatectomy (RP)- A systematic review. Clin Interv Aging. 2019;14:1997–2005.
  • Engberg S, Sereika SM. Effectiveness of pelvic floor muscle training for urinary incontinence: comparison within and between nonhomebound and homebound older adults. J Wound Ostomy Continence Nurs. 2016;43(3):291–300.
  • American Geriatrics Society. Beers criteria update expert panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019:1–21.
  • Sheu JJ, Tsai MT, Erickson SR, et al. Association between anticholinergic medication use and risk of dementia among patients with Parkinson’s disease. Pharmacotherapy. 2019;39(8):798–808.
  • Peyronnet B, Vurture G, Palma J, et al. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective review. Parkinsonism Relat Disord. 2018;57:22–26.
  • Gubbiotti M, Conte A, Di Stasi SM, et al. Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: a pilot study. Ther Adv Neurol Disord. 2019;12:1–9.
  • Westney OL, Bevan-Thomas R, Palmer JL, et al. Transurethral collagen injections for male intrinsic sphincter deficiency: the university of Texas-Houston experience. J Urol. 2005;174(3):994–997.
  • Lebret T, Cour F, Benchetrit J, et al. Treatment of postprostatectomy stress urinary incontinence using a minimally invasive adjustable continence balloon device, ProACT: results of a preliminary, multicenter, pilot study. Urology. 2008;71(2):256–260.
  • Finazzi Agrò E, Gregori A, Bianchi D, et al. Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: medium and long-term follow-up data of a national multicentric retrospective study. Neurourol Urodyn. 2019;38(7):1979–1984.
  • Rapoport D, Walter JR, Borawski KM, et al. The AdVance male sling: predictors of success [abstract]. J Urol Suppl. 2009;181:619.
  • Kim PH, Pinheiro LC, Atoria CL, et al. Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. J Urol. 2013;189(2):602–608.
  • Chapple C, Sievert KD, MacDiarmid S, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64(2):249–256.
  • Liao CH, Kuo HC. Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity. J Urol. 2013;189(5):1804–1810.
  • Suskind AM, Kowalik C, Quanstrom K, et al. The impact of frailty on treatment for overactive bladder in older adults. Neurourol Urodyn. 2019;38(7):1915–1923.
  • Colli J, Lloyd LK. Bladder neck closure and suprapubic catheter placement as definitive management of neurogenic bladder. J Spinal Cord Med. 2011;34(3):273–277.
  • De E, Pisters LL, Pettaway CA, et al. Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months. J Urol. 2007;177(6):2200–2204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.